Long-term followup needed to define role of infliximab in treatment of renal amyloidosis: comment on the case report by Elkayam et al.
Tweezer-Zaks
Nurit
N
Langevitz
Pnina
P
Livneh
Avi
A
D017772:Amyloid Neuropathies / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D003078:Colchicine / Q000627:therapeutic use; D010505:Familial Mediterranean Fever / Q000150:complications / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D011507:Proteinuria / Q000188:drug therapy* / Q000209:etiology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D003078:Colchicine